Suppr超能文献

预测接受胸腔置管术的恶性胸腔积液患者的生存率。

Predicting the survival in patients with malignant pleural effusion undergoing indwelling pleural catheter insertion.

作者信息

Akram Muhammad Junaid, Khalid Usman, Ashraf Mohammad Bilal, Bakar Muhammad Abu, Butt Faheem Mahmood, Khan Faheem

机构信息

Department of Internal Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, Pakistan.

Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, Pakistan.

出版信息

Ann Thorac Med. 2020 Oct-Dec;15(4):223-229. doi: 10.4103/atm.ATM_289_20. Epub 2020 Oct 10.

Abstract

CONTEXT

Malignant pleural effusion (MPE) is a common comorbid condition in advanced malignancies with variable survival.

AIMS

The aim of this study was to predict the survival in patients with MPE undergoing indwelling pleural catheter (IPC) insertion.

SETTINGS AND DESIGN

This was a cross-sectional study conducted at Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan.

METHODS

One hundred and ten patients with MPE who underwent IPC insertion from January 2011 to December 2019 were reviewed. Kaplan-Meier method was used to determine the overall survival (OS) of the patient's cohort with respect to LENT score.

STATISTICAL ANALYSIS USED

The IBM SPSS version 20 was used for statistical analysis.

RESULTS

We retrospectively reviewed 110 patients who underwent IPC insertion for MPE, with a mean age of 49 ± 15 years. 76 (69.1%) patients were females, of which majority 59 (53.6%) had a primary diagnosis of breast cancer. The LENT score was used for risk stratification, and Kaplan-Meier survival curves were used to predict the OS. The proportion of patients with low-risk LENT score had 91%, 58%, and 29% survival, the moderate-risk group had 76%, 52%, and 14% survival, and in the high-risk group, 61%, 15%, and 0% patients survived at 1, 3, and 6 months, respectively. In addition, there was a statistically significant survival difference ( = 0.05) in patients who received chemotherapy pre- and post-IPC insertion.

CONCLUSIONS

LENT score seems to be an easy and attainable tool, capable of predicting the survival of the patients with MPE quite accurately. It can be helpful in palliating the symptoms of patients with advanced malignancies by modifying the treatment strategies.

摘要

背景

恶性胸腔积液(MPE)是晚期恶性肿瘤中常见的合并症,患者生存期各异。

目的

本研究旨在预测接受留置胸腔导管(IPC)插入术的MPE患者的生存期。

设置与设计

这是一项在巴基斯坦拉合尔的沙卡特汗姆纪念癌症医院及研究中心开展的横断面研究。

方法

回顾了2011年1月至2019年12月期间接受IPC插入术的110例MPE患者。采用Kaplan-Meier法确定患者队列相对于LENT评分的总生存期(OS)。

所用统计分析方法

使用IBM SPSS 20版进行统计分析。

结果

我们回顾性分析了110例因MPE接受IPC插入术的患者,平均年龄为49±15岁。76例(69.1%)为女性,其中大多数59例(53.6%)的原发诊断为乳腺癌。采用LENT评分进行风险分层,并使用Kaplan-Meier生存曲线预测OS。低风险LENT评分的患者在1个月、3个月和6个月时的生存率分别为91%、58%和29%,中度风险组分别为76%、52%和14%,高风险组分别为61%、15%和0%。此外,IPC插入术前和术后接受化疗的患者在生存方面存在统计学显著差异(P = 0.05)。

结论

LENT评分似乎是一种简单且可实现的工具,能够相当准确地预测MPE患者的生存期。它有助于通过调整治疗策略缓解晚期恶性肿瘤患者的症状。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9673/7720744/7828d6c42f34/ATM-15-223-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验